301087.SZ
可孚医疗
SZSE · C 制造业 · CN
CNY 47.42
−1.27%Year over year
Reported trailing growth
- Revenue
- +25.7%
- EBITDA
- —
- EBIT
- +23.2%
- EPS
- +27.7%
- Free cash flow
- +40.2%
- Operating cash flow
- +26.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.4%
- EBITDA
- +9.4%
- EBIT
- +5.2%
- Net income
- +7.2%
- EPS
- +8.1%
- Free cash flow
- +401.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026